Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Potassium Iodide | HCID 4875 | — |
| Reactant | Propargyl bromide | HCID 7842 | — |
| Reactant | Potassium Carbonate | HCID 11430 | — |
| Reactant | Ammonium Chloride | HCID 25517 | — |
| Reactant | HCID 86719954 | HCID 86719954 | — |
| Solvent | Toluene | HCID 1140 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 71510469 | HCID 71510469 | 86.6% |
Reaction Steps
To a solution of 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[5-(2,6-difluoro-3-hydroxyphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone (1.82 g) and potassium carbonate (657 mg) in N,N-dimethylformamide (15 ml) are added, at room temperature, potassium iodide (289 mg) and 3-bromoprop-1-yne (755 mg)) (80 wt % in toluene). The reaction mixture is stirred at 80° C. for 4 h. Then the mixture is admixed with saturated aqueous solution of ammonium chloride and extracted with ethyl acetate. The combined organic phases are dried over sodium sulphate and concentrated. Purification by column chromatography gives 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2,6-difluoro-3-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (1.68 g).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09144238B2 |
|---|
| Source dataset | uspto-grants-2015_09 |
|---|
| ORD ID | ord-0e9bac1723be410aa95fc8440a341ec0 |
|---|
| Source note | uspto-grants-2015_09 |
|---|